medigraphic.com
ISSN 1727-897X (Electronic)

2012, Number 5

<< Back Next >>

Medisur 2012; 10 (5)

Cytogenetic Prenatal Diagnosis in the Province of Cienfuegos between 2007 and 2010

Díaz-Véliz JPA, Garrido MY, Guerra JA, Vidal HB

Language: Spanish
References: 19
Page: 399-404
PDF size: 155.25 Kb.


ABSTRACT

Background: cytogenetic prenatal diagnosis is nowadays part of the care provided in developed countries to high-risk pregnant women and is an indispensable component of preventive genetic programs driven by the World Health Organization.
Objective: To present the results of cytogenetic prenatal diagnosis in the province of Cienfuegos.
Methods: A chronological series study was developed at the Provincial Center of Medical Genetics of Cienfuegos on all cytogenetic prenatal diagnoses that were performed between 2007 and 2010. We analyzed causes of study, number of diagnoses and types of anomalies detected.
Results: during the period analyzed, 1172 amniocentesis of pregnant patients were processed and 1076 of them were diagnosed for 91, 81 % efficiency. 85,5 % of the cases studied were women over 37 years old. 32 chromosomal abnormalities were detected. The order of frequency of chromosomal abnormalities among the positive cases was: numerical aberrations (65, 63 %), structural aberrations (18, 75 %) and mosaics (15,63 %). The most common chromosomal abnormality was Down syndrome with 46,88 % of total aberrations detected.
Conclusions: the indicators analyzed behave similarly to those reported in literature both from our country or international.


REFERENCES

  1. Cerrillo Hinojosa M, Yerena de Vega MC, González Panzzi ME, Godoy H, Galicia J, Gutiérrez Nájar A. Amniocentesis genética en población de alto riesgo. Experiencia en 3,081 casos. Ginecol Obstet Mex. 2009;77(4):175-84.

  2. Pimentel Benítez HI, García Borrego A, Martín Cuesta N, Alonso Barba Y, Torres Palacios M, Suárez Mayedo U. Diagnóstico prenatal citogenético en Camagüey. Resultados de 20 años. Rev Cubana Genet Comunit. 2008;2(3):34-8.

  3. Quintana Aguilar J, Quiñones Maza O, Méndez Rosado LA, Lavista González M, González Noa CE, Hernández Pérez G. Resultados del diagnóstico prenatal cromosómico en Ciudad Habana. Rev Cubana Obstet Ginecol. 1999;25 (3):153-8.

  4. Ascurra M, Rodríguez S, Ayala A, Bataglia R, Atobe O. Amniocentesis para diagnóstico prenatal: 6 años de experiencia en Paraguay. Mem Inst Investig Cienc Salud. 2002;1(1):28-32.

  5. Méndez Rosado LA, Quiñones Maza O. Diagnóstico prenatal citogenético mediante cultivo de amniocitos. Rev Cubana Genet Comunit. 2009;3(1):7-15.

  6. Martínez de Santelices Cuervo A, Rizo López D, Amor Oruña MT, Fuentes Smith LE. Eficiencia del subprograma de diagnóstico prenatal citogenético en Ciudad de La Habana en el período 2005-2006. Rev Cubana Genet Comunit [revista en Internet]. 2012[citado 15 Sep 2012]; 4(3):[aprox. 5 p.]. Disponible en: http://bvs.sld.cu/revistas/rcgc/ v4n3/rcgc080310.pdf.

  7. Marcheco TB. La genética en la Salud Pública: el desafío del acceso de todos a los beneficios. Rev Cubana Genet Comunit. 2007;1(1):5-6.

  8. Méndez Rosado LA. Mosaicismo cromosómico en el diagnostico prenatal citogenético por cultivo de amniocitos [Tesis doctoral]. Ciudad de La Habana: Instituto Superior de Ciencias Médicas de la Habana. Centro Nacional de Genética Médica; 2009. [citado 15 Ene 2012] Disponible en: http://tesis.repo.sld.cu/205/1/Mendez_Rosado.pdf.

  9. Witters I, Devriendt K, Legius E, Matthijs G, Van Schoubroeck D, Van Assche FA, Fryns JP. Rapid prenatal diagnosis of trisomy 21 in 5 049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH). Prenat Diagn. 2002;22(1):29-33.

  10. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. Association between Maternal Age and Meiotic Recombination for Trisomy 21. Am J Hum Genet. 2005;76(1):91-9.

  11. Jobanputra V, Roy KK, Kriplani A, Kucheria K. Prenatal diagnosis of chromosomal abnormalities in women with high risk pregnancies. Indian J Med Res. 2001;114(10):148-55.

  12. Held K, Eiben B, Miny P. The long-term effect of external quality assessment on performance in service cytogenetics. Cytogenet Cell Genet. 2000;91(1-4):124-7.

  13. Corral E, Moreno R, Pérez N, Ojeda ME, Campusano L, Sepúlveda W. Diagnóstico citogenético prenatal: Experiencia de 10 años en el Hospital Regional de Rancagua. Rev Chil Ultrasonog. 2007;10(2):44-9.

  14. Forrester MB, Merz RD. Epidemiology of down síndrome (Trisomy 21), Hawaii, 1986-97. Teratology. 2002;5 (65):207-12.

  15. Thomas NS, Ennis S, Sharp AJ, Durkie M, Hassold TJ, Collins AR, Jacobs PA. Maternal sex chromosome nondisjunction: evidence for X chromosome_ specific risk factors. Hum Mol Genet. 2001;10(3):243-50.

  16. Sherman SL, Freeman SB, Allen EG, Lamb NE. Risk factors for nondisjunction of trisomy 21. Cytogenet Genome Res. 2005;111(3-4):273-80.

  17. Oliver TR, Feingold E, Yu K, Cheung V, Tinker S, Yadav-Shan M, et al. New insights human nondisjunction of chromosome 21 in oocytes. PLoS Genet[revista en Internet]. 2008[citado 20 Ene 2011];4(3):[aprox. 10 p.]. Disponible en: http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1000033.

  18. Petersen MB, Mikkelsen M. Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet. 2000;91(1 -4):199-203.

  19. Boyd PA, De Vigan C, Khoshnood B, Loane M, Game E, Dolk H. Survery of prenatal screening polices in Europe for structural malformations and chromosome anomalies, and their impact on deletion and termination rates for neural tube defects and Down's syndrome. BJOG. 2008;115(6):689-96.




2020     |     www.medigraphic.com